Lisa Newman, MD, MPH, FACS, FASCO

Commenting on this study on clinical genomic profiling for colorectal cancer, Lisa Newman, MD, MPH, FACS, FASCO, Chief of the Section of Breast Surgery and leader of the Multidisciplinary Breast Oncology Programs at Weill Cornell Medicine and NewYork-Presbyterian, commended the authors for studying a diverse population. “The different genetic tumor patterns would have been overlooked if the population were less diverse. The value of analyzing diverse populations is that it will improve our cancer research.”

Dr. Newman continued: “I conduct genomic research in breast cancer. As we uncover more broadly the comprehensive genetic profile [of different ethnicities], we will develop novel actionable patterns that will have clinical significance. But if we continue to study homogeneous populations, we will miss important opportunities to discover effective treatments.” 

DISCLOSURE: Dr. Newman has received research funding from Genentech.